SGX:O6Z - Lonza (SGD 79.97) LONZA GROUP LTD
Sector: Health Technology, Industry: Biotechnology

Add to WatchList


SGD 79.97    +0.0 (+0%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

9 Dec 2019


Overview

9 Dec 2019

52 Wk Range: 0.0 - 0.0

Day's Range: 79.97 - 79.97

Last Volume: 0

Current Yield: 4.57%

Projected Yield: 4.73%

Future Yield: [Friends Only]

Dividend Strength: [Friends Only]

9 Dec 2019

Metric O6Z S.Median
Beta 0 0.18
VaR 0 35.44
E.Shortfall 0 44.47
Liquidity 0 5,332.93

Fundamental

5 Dec 2019

PE: 8

Market Cap: 5.9B

Price Over Book: 0.693

Price Over Sales: 0.8

Return On Assets: 4.6%

Return On Equity: 10.2%

NAV Over Price: [Friends Only]

General

CEO: Marc Funk

Founded Year: 1897

Headquarters: Basel

Employees: 15,375

Shares Outstanding: 74.2M

Security Type: Stock

Useful Links
Homepage

Description

Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products. It operates through the following segments: Pharma & Biotech; Specialty Ingredients; and Corporate. The Pharma & Biotech segment comprises development and manufacture of customized active pharmaceutical ingredients and biopharmaceuticals as well as formulation services and delivery systems. The Specialty Ingredients segment consists of two divisions, consumer health and consumer resources and protection. The Corporate segment includes corporate functions, such as finance and accounting, legal, communication, information technology, and human resources. The company was founded in 1897 and is headquartered in Basel, Switzerland.